Facultad de Medicina
Centro académico
Hospital Duran i Reynals
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Duran i Reynals (37)
2024
-
First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN
Breast Cancer Research and Treatment
2023
2022
-
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications
Histopathology, Vol. 81, Núm. 6, pp. 826-840
-
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice
International Journal of Hematology, Vol. 116, Núm. 3, pp. 381-392
-
Is short-course radiotherapy and total neoadjuvant therapy the new standard of care in locally advanced rectal cancer? A sensitivity analysis of the RAPIDO clinical trial
Annals of Oncology, Vol. 33, Núm. 8, pp. 786-793
-
Learning in times of stress: Lessons from COVID-19 that will last throughout this century
European Journal of Internal Medicine, Vol. 96, pp. 1-4
-
Meat Intake, Cooking Methods, Doneness Preferences and Risk of Gastric Adenocarcinoma in the MCC-Spain Study
Nutrients, Vol. 14, Núm. 22
-
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC
Transplantation and Cellular Therapy, Vol. 28, Núm. 4, pp. 204.e1-204.e10
2021
-
Bayesian interpretation of the ESMO guideline for localized colorectal cancer: a better IDEA
Annals of Oncology
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- And high-risk myeloma
Blood, Vol. 137, Núm. 1, pp. 49-60
-
R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group
Cancer Medicine, Vol. 10, Núm. 4, pp. 1314-1326
-
SUNRISE-DI study. The daily sunrise is easier to predict than the benefit of adjuvant treatment in colon cancer
ESMO Open
2020
-
Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain)
Environment International, Vol. 144
-
Validation of self-reported perception of proximity to industrial facilities: MCC-Spain study
Environment International, Vol. 135
2019
-
Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer
International Journal of Gynecological Cancer, Vol. 29, Núm. 7, pp. 1141-1147
-
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma
Leukemia and Lymphoma
2018
-
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group
American Journal of Hematology, Vol. 93, Núm. 7, pp. 867-873
-
Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy
Bone Marrow Transplantation, Vol. 53, Núm. 8, pp. 960-966
-
The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism
Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 230-242
2017
-
Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin’s lymphoma in patients older than 50 years
Annals of Hematology, Vol. 96, Núm. 1, pp. 9-16